Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
De Agostini is a major Italian international holding company with a diversified portfolio across publishing, media, gaming, and financial services. In the healthcare and life sciences sector, the group operates primarily through its subsidiary, DeA Capital Alternative Funds SGR, which manages a dedicated Life Sciences fund. This fund focuses on investing in European clinical-stage biotechnology and medical technology companies to foster innovation in therapeutics and diagnostics. While the parent company is a conglomerate, its strategic investments make it a significant financial player in the European biotech ecosystem. The group provides growth capital and strategic support to portfolio companies aiming to address unmet medical needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on De Agostini.